These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 10091159

  • 1. Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients.
    Gamberini MR, Fortini M, Gilli G, Testa MR, De Sanctis V.
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():867-9. PubMed ID: 10091159
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy.
    Platis O, Anagnostopoulos G, Farmaki K, Posantzis M, Gotsis E, Tolis G.
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():279-81. PubMed ID: 16462711
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major.
    Suvarna J, Ingle H, Deshmukh CT.
    Indian Pediatr; 2006 May; 43(5):393-400. PubMed ID: 16735760
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evolution of glucose intolerance and diabetes in transfused patients with thalassemia.
    Kattamis C, Ladis V, Tsoussis D, Kaloumenou I, Theodoridis C.
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():267-71. PubMed ID: 16462709
    [Abstract] [Full Text] [Related]

  • 10. Severe infections in thalassaemic patients: prevalence and predisposing factors.
    Rahav G, Volach V, Shapiro M, Rund D, Rachmilewitz EA, Goldfarb A.
    Br J Haematol; 2006 Jun; 133(6):667-74. PubMed ID: 16704445
    [Abstract] [Full Text] [Related]

  • 11. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR, De Sanctis V, Gilli G.
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
    [Abstract] [Full Text] [Related]

  • 12. Diabetes mellitus in children suffering from beta-thalassaemia.
    el-Hazmi MA, al-Swailem A, al-Fawaz I, Warsey AS, al-Swailem A.
    J Trop Pediatr; 1994 Oct; 40(5):261-6. PubMed ID: 7807619
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload.
    Zuppinger K, Molinari B, Hirt A, Imbach P, Gugler E, Tönz O, Zurbrügg RP.
    Helv Paediatr Acta; 1979 Oct; 34(3):197-207. PubMed ID: 500381
    [Abstract] [Full Text] [Related]

  • 17. Glucose tolerance and beta-cell secretion in patients with thalassaemia major.
    Mangiagli A, Italia S, Campisi S.
    J Pediatr Endocrinol Metab; 1998 Oct; 11 Suppl 3():985-6. PubMed ID: 10091179
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardiac disease in beta-thalassaemia major: Is it reversible?
    Atiq M, Bana M, Ahmed US, Bano S, Yousuf M, Fadoo Z, Khurshid M.
    Singapore Med J; 2006 Aug; 47(8):693-6. PubMed ID: 16865210
    [Abstract] [Full Text] [Related]

  • 20. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping.
    Khalifa AS, Salem M, Mounir E, El-Tawil MM, El-Sawy M, Abd Al-Aziz MM.
    Pediatr Diabetes; 2004 Sep; 5(3):126-32. PubMed ID: 15450007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.